Document Detail


Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity.
MedLine Citation:
PMID:  2288384     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report a 3-year-11-month-old boy who manifested action myoclonus only. Histochemical analysis of the quadriceps muscle revealed subsarcolemmal hyperactivity. The administration of 5-hydroxytryptophan and carbidopa dramatically improved the action myoclonus and reduced an amplitude of giant somatosensory evoked potentials. A nosological relation of this case with "essential myoclonus" and mitochondrial encephalomyopathy was discussed.
Authors:
K Nakano; T Hayakawa; K Shishikura; M Ohsawa; H Suzuki; Y Fukuyama
Related Documents :
10169954 - The impact of transfer patients on medicare inpatient cost per discharge.
10930494 - Office-based wire-guided open breast biopsy under local anesthesia is accurate and cost...
21795824 - Tubercular spinal epidural abscess involving the dorsal-lumbar-sacral region without os...
22430124 - Successful management of plastic bronchitis in a child post fontan: case report and lit...
18990274 - Urological pathology causing free air under the diaphragm?
11190814 - Enhanced surveillance for meningococcal disease in queensland in 1999.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Brain & development     Volume:  12     ISSN:  0387-7604     ISO Abbreviation:  Brain Dev.     Publication Date:  1990  
Date Detail:
Created Date:  1991-03-22     Completed Date:  1991-03-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7909235     Medline TA:  Brain Dev     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  516-20     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Tokyo Women's Medical College, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
5-Hydroxytryptophan / therapeutic use*
Carbidopa / therapeutic use*
Child, Preschool
Humans
Male
Muscles / pathology,  ultrastructure
Muscular Diseases / complications,  drug therapy*,  pathology
Myoclonus / drug therapy*,  etiology
Chemical
Reg. No./Substance:
38821-49-7/Carbidopa; 56-69-9/5-Hydroxytryptophan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Electron microscopic study on the homozygote (Ml/Ml) of the macular mutant mouse.
Next Document:  Epileptic seizures difficult to differentiate from alternating hemiplegia in infants: a case report.